Results 51 to 60 of about 90,057,531 (289)

Pharmaceutical patents and the right to health – Portugal and Brazil (Vol.13, N.1)

Janus.net, 2022
The defence of the patent system's legitimacy, namely in the pharmaceutical field, is consolidated, although it is not exempt from criticism. Historically, when the patent law, a legal monopoly right, is confronted with the right of access to
Ruben Bahamonde Delgado
doaj   +1 more source

Accelerated Access to Medicines: An Ethical Analysis [PDF]

Therapeutic Innovation & Regulatory Science, 2017
In recent years, a range of initiatives have been introduced to provide patients with access to medicines outside of traditional regulatory and/or funding channels; we term these processes "accelerated access to medicines." These generally take 1 of 3 forms: those that provide access by making existing regulatory and funding processes more efficient ...
Pace, J, Ghinea, N, Kerridge, I, Lipworth, W   +3 more
openaire   +3 more sources

Ewing Sarcoma in Infants and Children Under 2 Years of Age: A French Retrospective Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Ewing sarcoma, the second most common primary bone cancer in children, requires intensive treatment that may lead to significant long‐term sequelae, particularly in infants. We retrospectively analyzed data from 1621 French patients treated between 1988 and 2015 within the EW88/93/97 or EE99 trials, focusing on 17 infants diagnosed before 24 ...
Elodie Verdier, Nathalie Cozic, Marie‐Dominique Tabone, Gaelle Pierron, Perrine Marec‐Berard, Sarah Winter, Gabriel Revon‐Rivière, Cyril Lervat, Dominique Plantaz, Marie‐Pierre Castex, Gregory Guimard, Estelle Thebaud, Stephanie Proust, Laure Saumet, Natacha Entz‐Werle, Sophie Taque, Cécile Vérité, Marta Jimenez, Nathalie Gaspar   +18 more
wiley   +1 more source

Developing an intuitive decision support system for equitable vaccine distribution during pandemics

Scientific Reports
Effective organization of the vaccine supply chain is vital to achieve high vaccination rates in pandemics. This paper presents a novel approach for developing a decision support system (DSS) to support health officials and policymakers who must make ...
Lise Boey, Hossein Baharmand, Ross Owen Phillips, Nico Vandaele, Burcu Balcik, Jan Ove Kjøndal, Asle Birkeland, Håvard Fossli, Naima Saeed, Catherine Decouttere   +9 more
doaj   +1 more source

Associations of mental disorders and neurotropic parasitic diseases: a meta-analysis in developing and emerging countries

BMC Public Health, 2019
Background Although they are declining worldwide, neurotropic parasitic diseases are still common in developing and emerging countries. The aim of this study was to estimate the pooled prevalence and pooled association measures of comorbidities between ...
Labanté Outcha Daré, Pierre-Emile Bruand, Daniel Gérard, Benoît Marin, Valerie Lameyre, Farid Boumédiène, Pierre-Marie Preux   +6 more
doaj   +1 more source

A multi-country survey on access to healthcare and treatment services among individuals with critical medical care needs during the first wave of the pandemic

BMC Public Health, 2023
Background Healthcare services were significantly interrupted during the early phase of the COVID-19 pandemic. The aim of the present study was to determine the associations between sociodemographic factors and healthcare access during the first wave of ...
Morenike Oluwatoyin Folayan, Roberto Ariel Abeldaño Zuñiga, Jorma I. Virtanen, Oliver C. Ezechi, Muhammad Abrar Yousaf, Ala’a B. Al-Tammemi, Mohammed Jafer, Passent Ellakany, Eshrat Ara, Martin Amogre Ayanore, Anthonia Omotola Ishabiyi, Balgis Gaffar, Nourhan M. Aly, Joanne Lusher, Maha El Tantawi, Annie L. Nguyen   +15 more
doaj   +1 more source

Provider and Parent Perspectives on Prioritizing the “Asking and Monitoring” Pediatric Cancer Psychosocial Standards of Care

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background The Standards for Psychosocial Care for Children with Cancer and Their Families (“Standards”) are evidence‐based guidelines for psychosocial care in pediatric oncology. Care related to the three “Asking and Monitoring” Standards—Assessment of Psychosocial Needs, Assessment of Financial Needs, and Monitoring Neurocognitive Problems ...
Julia B. Tager, Natalie Koskela‐Staples, Emily M. Pariseau, Michele Scialla, Kimberly Buff, Lori Wiener, Victoria Sardi Brown, Anne E. Kazak, Kimberly S. Canter   +8 more
wiley   +1 more source

Judicialization of access to medicines in four Latin American countries: a comparative qualitative analysis

International Journal for Equity in Health, 2019
Background The valuation of medicines as health needs vary depending on the stakeholders involved (users, prescribers, managers, etc.) and their expectations. These factors modulate the role of medicines as a health need and influence access to medicines,
Claudia Marcela Vargas-Pelaez, Marina Raijche Mattozo Rover, Luciano Soares, Carine Raquel Blatt, Aukje K. Mantel-Teeuwisse, Francisco Augusto Rossi, Luis Guillermo Restrepo, María Cristina Latorre, José Julián López, María Teresa Bürgin, Consuelo Silva, Silvana Nair Leite, Mareni Rocha Farias   +12 more
doaj   +1 more source

Safety and Effectiveness of a High‐Dose, Tailored Tissue Plasminogen Activator Therapy Protocol: A Joint Pediatric Hematology and Cardiac ICU Quality Improvement Initiative Analysis

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Pediatric thromboembolism is increasingly encountered in critical care. Systemic thrombolysis with tissue plasminogen activator (tPA) facilitates vessel or valve patency, yet pediatric‐specific protocols remain undefined, and safety concerns persist. Objective To evaluate the efficacy and safety of a tailored, prolonged systemic tPA
Eran Shostak, Oded Gilad, Yael Feinstein, Sigal Nakav, Ofer Schiller, Joanne Yacobovich   +5 more
wiley   +1 more source

Patent dispute: Delhi High Court gives a boost to access to affordable medicines [PDF]

, 2010
The Delhi High Court has rejected the petition filed by Bayer Corporation seeking to stop the Drugs Controller of India (DCGI) from registering a generic version of a patented cancer drug.
Menghaney, Leena
core